Effect of Long-Term Empagliflozin Therapy on Plasma Beta-Hydroxy Butyrate (β-OHB)-Lack of Effect of Concomitant Insulin, GLP-1 Agonist, or Pioglitazone Therapy

被引：0
|
作者：
Ortiz, Luis C.
Wortham, Joy
Pinkson, Sheila
Trejo, Jonathan
Mendoza, Amiel S.
Chen, Xi
Tripathy, Devjit
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-895-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study
    Kumashiro, Naoki
    Yoshihara, Tomoaki
    Kanazawa, Yoshie
    Shimizu, Tomoak
    Watada, Hirotaka
    Tanaka, Yasushi
    Fujitani, Yoshio
    Kawamori, Ryuzo
    Hirose, Takahisa
    ENDOCRINE JOURNAL, 2007, 54 (01) : 163 - 166
  • [42] Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure
    Kimura, T.
    Obata, A.
    Shimoda, M.
    Hirukawa, H.
    Kanda-Kimura, Y.
    Nogami, Y.
    Kohara, K.
    Nakanishi, S.
    Mune, T.
    Kaku, K.
    Kaneto, H.
    DIABETES & METABOLISM, 2018, 44 (03) : 250 - 260
  • [43] Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension
    Takayoshi Tsutamoto
    Toshinari Tanaka
    Keizo Nishiyama
    Masayuki Yamaji
    Chiho Kawahara
    Masanori Fujii
    Takashi Yamamoto
    Minoru Horie
    Hypertension Research, 2009, 32 : 670 - 674
  • [44] Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension
    Tsutamoto, Takayoshi
    Tanaka, Toshinari
    Nishiyama, Keizo
    Yamaji, Masayuki
    Kawahara, Chiho
    Fujii, Masanori
    Yamamoto, Takashi
    Horie, Minoru
    HYPERTENSION RESEARCH, 2009, 32 (08) : 670 - 674
  • [45] Long-term Effect of Efonidipine Therapy on Plasma Aldosterone and Left Ventricular Mass Index in Patients With Essential Hypertension
    Tsutamoto, Takayoshi
    Nishiyama, Keizo
    Yamaji, Masayuki
    Kawahara, Chiho
    Fujii, Masanori
    Yamamoto, Takashi
    Horie, Minoru
    CIRCULATION, 2009, 120 (18) : S1006 - S1006
  • [46] EFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS - STUDIES WITH HIGH-DEFINITION COMPUTERIZED-TOMOGRAPHY
    JOHNSTON, DG
    HALL, K
    KENDALLTAYLOR, P
    PATRICK, D
    WATSON, M
    COOK, DB
    LANCET, 1984, 2 (8396): : 187 - 192
  • [47] Adding a DPP-4 Inhibitor to Ongoing Therapy with a GLP-1 Receptor Agonist and Metformin Increases Intact GLP-1, But Does Not Change Insulin or Glucagon Secretion nor Plasma Glucose Excursions following a Mixed Test Meal in Patients with Type 2 Diabetes
    Nauck, Michael A.
    Kahle, Melanie
    Baranov, Oleg
    Deacon, Carolyn F.
    Holst, Jens J.
    DIABETES, 2015, 64 : A3 - A3
  • [48] Lack of long-term protective effect of antioxidant/anti-inflammatory therapy in transplant-induced ischemia/reperfusion injury
    Tain, You-Lin
    Muller, Veronika
    Szabo, Attila
    Dikalova, Anna
    Griendling, Kathy
    Baylis, Chris
    AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (03) : 213 - 217
  • [49] Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis
    Szczucinski, A
    Losy, J
    FOLIA NEUROPATHOLOGICA, 2004, 42 (01) : 15 - 18
  • [50] Continuous subcutaneous insulin infusion therapy: long-term impact upon plasma lipids, lipoproteins and HbA1c
    Webb, R. J.
    Davies, I. G.
    Purewal, T. S.
    Weston, P. J.
    Morrison, G.
    Abayomi, J. C.
    DIABETIC MEDICINE, 2014, 31 : 70 - 70
12345